| Kalliopi K Nestor, MD | |
|
1001 E 2nd St, Coudersport, PA 16915-8161 | |
| (814) 274-9300 | |
| Not Available |
| Full Name | Kalliopi K Nestor |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 24 Years |
| Location | 1001 E 2nd St, Coudersport, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720194608 | NPI | - | NPPES |
| 1906113 | Other | PA | BLUE SHIELD |
| MD429725 | Other | PA | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD429725 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Canton-potsdam Hospital | Potsdam, NY | Hospital |
| Gouverneur Hospital | Gouverneur, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Canton-potsdam Hospital | 6204827280 | 195 |
News Archive
Among nearly 375,000 U.S. women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity, with much of the difference accounted for by biological differences, according to a study in the January 13 issue of JAMA.
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.
› Verified 2 days ago
| Entity Name | Canton-potsdam Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568548782 PECOS PAC ID: 6204827280 Enrollment ID: O20040519000761 |
News Archive
Among nearly 375,000 U.S. women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity, with much of the difference accounted for by biological differences, according to a study in the January 13 issue of JAMA.
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.
› Verified 2 days ago
| Entity Name | Physical Medicine & Rehabilitation Of Long Island Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003293366 PECOS PAC ID: 4486966157 Enrollment ID: O20150709000313 |
News Archive
Among nearly 375,000 U.S. women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity, with much of the difference accounted for by biological differences, according to a study in the January 13 issue of JAMA.
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kalliopi K Nestor, MD 1001 E 2nd St, Coudersport, PA 16915-8161 Ph: () - | Kalliopi K Nestor, MD 1001 E 2nd St, Coudersport, PA 16915-8161 Ph: (814) 274-9300 |
News Archive
Among nearly 375,000 U.S. women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity, with much of the difference accounted for by biological differences, according to a study in the January 13 issue of JAMA.
The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.
› Verified 2 days ago
Mrs. Adriane Elizabeth Biancuzzo, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1001 E 2nd St, Coudersport, PA 16915 Phone: 814-274-9300 | |
Eileen Powell, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1001 East Second Street, Coudersport, PA 16915 Phone: 814-274-9300 |